Team

Sean McCarthy, D.Phil.
Transactional Partner

Sean joined Pappas in 2006 after ten years of experience in business development, program management and research management in the biotech industry. Immediately prior to Pappas he served as Vice President of Business Development at SGX Pharmaceuticals Inc., an oncology-focused biotechnology company located in San Diego. Under his leadership SGX entered into a wide range of strategic partnerships with major pharmaceutical companies including a $515 million oncology alliance with Novartis focused on the development of novel therapies for chronic myelogenous leukemia. Prior to SGX, Sean was Associate Director of Program Management at Millennium Pharmaceuticals where he managed drug discovery programs. Prior to joining the Program Management group at Millennium, Sean managed an interdisciplinary team of scientists that developed novel genomic techniques for the identification of therapeutic proteins in the context of a major alliance with Eli Lilly. Sean is the author of 17 peer-reviewed scientific publications and an inventor on 29 issued patents and filed patent applications. He is a board observer at Afferent Pharmaceuticals, CoLucid Pharmaceuticals, LEAD Therapeutics, Optherion Inc., Genstruct and TyRx Pharma.

Education

King’s College London (B.Sc. in Biochemistry and Pharmacology)
Oxford University (Doctorate – D.Phil.)
UC San Diego Rady School of Management (MBA)